Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Derm CasesDermatology / Paediatrics / Neurosurgery / Plastic surgery

Derm Cases · Dermatology / Paediatrics / Neurosurgery / Plastic surgery

OSCE — giant congenital melanocytic naevus: size risk, melanoma, and NCM MRI

An 8-minute OSCE station on congenital melanocytic naevus size classification, melanoma risk in giant CMN, neurocutaneous melanocytosis screening indications, and when to biopsy or image.

8 minosce1 min readVerification in progress

Target exams

NEET-PGINICETUSMLEPLABMRCP
On this page
Study tools

Target exams

NEET-PGINICETUSMLEPLABMRCP
Prompt
An 8-minute OSCE station on congenital melanocytic naevus size classification, melanoma risk in giant CMN, neurocutaneous melanocytosis screening indications, and when to biopsy or image.

Brief (to candidate)

A newborn has a large dark plaque covering much of the back (projected adult size ≥20 cm) with numerous satellite naevi. Parents ask about "removal now" and cancer risk. You have 8 minutes to classify, counsel melanoma/NCM risk, and plan MRI and surveillance.

Candidate instructions

  1. Define CMN and size classes (small/medium/large-giant).
  2. State approximate melanoma risk emphasis for giant CMN.
  3. Identify NCM high-risk features and MRI timing.
  4. Describe when to biopsy within a CMN.
  5. Outline multidisciplinary management (not automatic radical newborn excision of all giant lesions).

Examiner checklist (mark each domain / 10)

DomainKey actions expected
Definition / geneticsMelanocytic naevus present at birth/early weeks; mosaic RAS-MAPK (NRAS common in giant CMN)[5][6]
Size classificationProjected adult size: small <1.5 cm; medium 1.5–19.9 cm; large/giant ≥20 cm (or large % BSA); satellites increase systemic concern
Melanoma riskHighest in giant CMN; risk often quoted in the 5–15% lifetime range in classic teaching (varies by series); may arise deep and in childhood — not only adult surface change; full-thickness biopsy of suspicious nodules[2][4]
NCM screeningPosterior axial giant CMN + many satellites → risk of neurocutaneous melanocytosis; MRI brain and spine ideally in first months of life; neurology if seizures/raised ICP/developmental issues[2][3]
Surveillance / surgerySerial photography/exam; plastic surgery/derm for staged excision or observation depending on size, site, psychosocial needs — not one-size emergency total removal in all newborns
OtherPalpebral involvement → ophthalmology; change (nodule, ulcer, colour shift, bleeding) → urgent specialist review
CommunicationHonest risk counselling without fatalism; safety-net neurologic symptoms

Model key actions

  • Classify as giant CMN with satellites — highest risk category for melanoma/NCM counselling.[2]
  • Arrange early MRI neuraxis for NCM risk stratification.[3]
  • Biopsy new nodules/change; plan long-term multidisciplinary follow-up.[4]

Common errors

  • Treating all CMN as identical melanoma risk.
  • Missing NCM MRI indications in axial giant + satellites.
  • Superficial shave of deep concerning nodule.
  • Promising that complete excision eliminates all neurologic risk if NCM already present.
[2] [3] [4]
References5ShowHide
  1. [2]Viana AC, Gontijo B, Bittencourt FV. Giant congenital melanocytic nevus. Anais Brasileiros de Dermatologia, 2013.PMID 24474093
  2. [3]Ruth J. Congenital melanocytic nevus syndrome: An association between congenital melanocytic nevi and neurological abnormalities. Seminars in pediatric neurology, 2024.PMID 39389659
  3. [4]Alos L, Carrasco A, Teixidó C, et al. Melanoma on congenital melanocytic nevi. Pathology, research and practice, 2024.PMID 38518732
  4. [5]Zayour M, Lazova R. Congenital melanocytic nevi. Clinics in laboratory medicine, 2011.PMID 21549240
  5. [6]Aimaier R, Chung M, Zhu H, et al. Spatiotemporal expression of NRAS and occurrence of giant congenital melanocytic nevi. Experimental dermatology, 2022.PMID 35020224
PreviousOSCE — genodermatoses overview: mechanism map and referral pathwayDermatology / Genetics / PaediatricsNextOSCE — groin, feet and nails: tinea cruris, pedis and onychomycosisDermatology / Infectious Disease / Primary Care